Mr. Speaker, I have the honour to present, in both official languages, the 20th report of the Standing Committee on Health, entitled “Towards Open Science: Promoting Innovation in Pharmaceutical Research and Development and Access to Affordable Medications both in Canada and Abroad”. Pursuant to Standing Order 109, the committee requests that the government table a comprehensive response to this report. Basically, the report encourages funding investments in clinical research and innovation and also wants to ensure that the research results in lower costs for pharmaceuticals.
I want to thank all members of the committee, who worked hard on this, as well as the analysts and the clerk of the committee, who produced a wonderful report.